This is a preview of subscription content, log in via an institution to check access.
Literature Cited
V. Z. Gorkin and I. V. Verevkina, Vopr. Med. Khim., No. 3, 315 (1963).
M. D. Mashkovskii, V. Z. Gorkin, N. I. Andreeva, et al., Farmakol. Toksikol., No. 5, 531 (1975).
M. D. Mashkovskii, V. Z. Gorkin, N. I. Andreeva, et al., Farmakol. Toksikol., No. 3, 267 (1974).
B. Ekstedt, Med. Biol.,57, 220 (1979).
C. J. Fowler, B. A. Callingham, T. J. Mantle, et al., Biochem. Pharmacol.,27, 97 (1978).
M. D. Houslay, K. F. Tipton, and M. B. H. Youdim, Life Sci.,19, 467 (1976).
J. P. Johnston, Biochem. Pharmacol.,17, 1285 (1968).
A. J. Lees, K. M. Shaw, J. Kohout, et al., Lancet,2, 791 (1977).
N. H. Neff, H. Y. T. Yang, and C. Goridis, Life Sci.,13, 74 (1973).
L. Oreland, Arch. Biochem.,46, 410 (1971).
G. L. Peterson, Anal. Biochem.,83, 346 (1977).
L. S. Seiden and J. Westley, Biochim. Biophys. Acta58, 363 (1962).
H. Y. T. Yang and N. H. Neff, J. Pharmacol. Exp. Ther.,189, 733 (1974).
Additional information
Laboratory of Pharmacology, S. Ordzhonikidze All-Union Pharmaceutical Chemistry Research Institute. Laboratory of Biogenic Amines and Other Nitrogenous Compounds, Institute of Biological and Medical Chemistry, Academy of Medical Sciences of the USSR, Moscow. Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 91, No. 2, pp. 169–171, February, 1981.
Rights and permissions
About this article
Cite this article
Mashkovskii, M.D., Gorkin, V.Z., Verevkina, I.V. et al. Selective inhibition of type a monoamine oxidase by pyrazidol. Bull Exp Biol Med 91, 149–151 (1981). https://doi.org/10.1007/BF00835392
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00835392